Glycomet: Effective Blood Glucose Management for Diabetes Control
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.24 | $43.32 (0%) | 🛒 Add to cart |
| 270 | $0.21 | $64.99 $57.43 (12%) | 🛒 Add to cart |
| 360 | $0.20
Best per pill | $86.65 $71.54 (17%) | 🛒 Add to cart |
Similar products
Glycomet is a widely prescribed oral antidiabetic medication, primarily containing Metformin Hydrochloride. It belongs to the biguanide class and is a first-line therapy for managing type 2 diabetes mellitus. By reducing hepatic glucose production and improving insulin sensitivity, Glycomet helps maintain optimal blood sugar levels. It is often recommended as part of a comprehensive treatment plan that includes diet and exercise.
Features
- Contains Metformin Hydrochloride as the active ingredient
- Available in various strengths: 250 mg, 500 mg, 850 mg, and 1000 mg tablets
- Immediate-release and extended-release formulations
- White to off-white, film-coated, round biconvex tablets
- Manufactured under strict quality control standards
Benefits
- Effectively lowers and stabilizes blood glucose levels
- Reduces the risk of diabetes-related complications such as neuropathy and retinopathy
- May support modest weight loss or weight maintenance in some patients
- Does not typically cause hypoglycemia when used as monotherapy
- Can improve lipid profiles by lowering LDL cholesterol and triglycerides
- Often improves overall glycemic control as part of a combination therapy regimen
Common use
Glycomet is primarily indicated for the management of type 2 diabetes mellitus in adults and children over 10 years of age. It is used when diet and exercise alone have not achieved sufficient glycemic control. It may be prescribed as monotherapy or in combination with other oral antidiabetic agents or insulin. Glycomet is also used off-label in certain cases of polycystic ovary syndrome (PCOS) to help improve insulin sensitivity and regulate menstrual cycles.
Dosage and direction
The dosage of Glycomet must be individualized based on the patient’s condition and response, under medical supervision. The usual starting dose for adults is 500 mg twice daily or 850 mg once daily, taken with meals. The dosage may be increased gradually, at weekly intervals, by 500 mg per week or 850 mg every two weeks, up to a maximum of 2000–2550 mg per day, divided into 2–3 doses. Extended-release tablets are usually taken once daily with the evening meal. Always swallow the tablet whole; do not crush or chew. Dosage for pediatric patients (10–16 years) typically starts at 500 mg twice daily, with a maximum dose of 2000 mg per day.
Precautions
- Regular monitoring of renal function is advised before and during treatment.
- Avoid use in conditions that may impair renal function or lead to hypoxia, such as dehydration, severe infection, or acute congestive heart failure.
- Temporary discontinuation may be necessary before procedures involving use of iodinated contrast materials.
- Use with caution in elderly patients due to potential decreased renal function.
- Patients should be advised about the symptoms of lactic acidosis and instructed to seek immediate medical attention if they occur.
- Vitamin B12 levels should be monitored periodically, as long-term use may decrease absorption.
Contraindications
- Hypersensitivity to metformin or any component of the formulation.
- Severe renal impairment (eGFR below 30 mL/min/1.73 m²) or renal disease.
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis.
- History of lactic acidosis.
- Acute conditions predisposing to renal dysfunction, such as dehydration, severe infection, or shock.
- Hepatic impairment.
- Acute or chronic disease which may cause tissue hypoxia (e.g., cardiac or respiratory failure, recent myocardial infarction).
Possible side effect
Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal discomfort, and loss of appetite. These often subside with continued use. Other possible side effects include a metallic taste, decreased vitamin B12 absorption, and, rarely, lactic acidosis—a serious but rare condition requiring immediate medical attention. Hypoglycemia is uncommon when used alone but may occur when combined with other antidiabetic agents.
Drug interaction
Glycomet may interact with several medications, including:
- Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, vancomycin) that are eliminated by renal tubular secretion, potentially increasing metformin levels.
- Alcohol, which can increase the risk of lactic acidosis.
- Glucocorticoids, diuretics, and sympathomimetics may reduce the hypoglycemic effect.
- Hypoglycemic agents like sulfonylureas or insulin may enhance hypoglycemic effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.
Overdose
Overdose of Glycomet may lead to hypoglycemia or lactic acidosis. Symptoms of hypoglycemia include sweating, trembling, blurred vision, and confusion; lactic acidosis may present with nausea, vomiting, abdominal pain, and hyperventilation. In case of suspected overdose, seek immediate medical attention. Hypoglycemia should be treated with oral glucose or intravenous dextrose; lactic acidosis may require hemodialysis.
Storage
Store Glycomet tablets at room temperature (15–30°C), in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and before starting or altering any medication regimen. Do not disregard professional medical advice or delay seeking it based on information provided here.
Reviews
Glycomet has been extensively studied and is widely regarded as effective and safe for managing type 2 diabetes. Clinical trials and patient reports often highlight its efficacy in reducing HbA1c levels and its favorable side effect profile compared to some other antidiabetic agents. Many users appreciate that it does not typically cause weight gain or hypoglycemia when used alone. Some note initial gastrointestinal side effects, which often diminish over time. Overall, it remains a cornerstone in diabetes management protocols worldwide.